Compound Summary

nadide
  Compound Information
 nadide

Compound Name:

nadide

Compound CID:

5892

Synonyms:

nadide

NAD+

53-84-9

coenzyme I

beta-NAD

More...

Iupac Name:

[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] [(2R,3S,4R,5R)-5-(3-carbamoylpyridin-1-ium-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl phosphate

InChI:

InChI=1S/C21H27N7O14P2/c22-17-12-19(25-7-24-17)28(8-26-12)21-16(32)14(30)11(41-21)6-39-44(36,37)42-43(34,35)38-5-10-13(29)15(31)20(40-10)27-3-1-2-9(4-27)18(23)33/h1-4,7-8,10-11,13-16,20-21,29-32H,5-6H2,(H5-,22,23,24,25,33,34,35,36,37)/t10-,11-,13-,14-,15-,16-,20-,21-/m1/s1

InChIKey:

BAWFJGJZGIEFAR-NNYOXOHSSA-N

Canonical Smiles:

C1=CC(=C[N+](=C1)C2C(C(C(O2)COP(=O)([O-])OP(=O)(O)OCC3C(C(C(O3)N4C=NC5=C(N=CN=C54)N)O)O)O)O)C(=O)N

Isomeric Smiles:

C1=CC(=C[N+](=C1)[C@H]2[C@@H]([C@@H]([C@H](O2)COP(=O)([O-])OP(=O)(O)OC[C@@H]3[C@H]([C@H]([C@@H](O3)N4C=NC5=C(N=CN=C54)N)O)O)O)O)C(=O)N

Molecular Weight:

663.4

Molecular Formula:

C21H27N7O14P2

  Compound Structure
 2D Structure:
 3D Structure:
  Computed Properties
 nadide

Molecular Weight:

663.4

Molecular Formula:

C21H27N7O14P2

Hydrogen Bond Donor Count:

7

Hydrogen Bond Acceptor Count:

18

Rotatable Bond Count:

11

Heavy Atom Count:

44

Complexity:

1120

  Synonyms
 nadide

nadide nadide

nadide

NAD+

53-84-9

coenzyme I

beta-NAD

Codehydrase I

nicotinamide adenine dinucleotide

beta-NAD+

Cozymase I

Codehydrogenase I

diphosphopyridine nucleotide

beta-Diphosphopyridine nucleotide

beta-nicotinamide adenine dinucleotide

COZYMASE

Nicotinamide dinucleotide

CO-I

Enzopride

NAD

Oxidized diphosphopyridine nucleotide

CO-1

Pyridine, nucleotide diphosphate

Adenine-nicotinamide dinucleotide

Nicotineamide adenine dinucleotide

Nicotinamide-adenine dinucleotide

beta-DPN

Nadidum INN-Latin

Nadida INN-Spanish

C21H27N7O14P2

MFCD00036253

nicotinamide adenine dinucleotide oxidized

beta-Diphosphopyridinenucleotide

CHEBI:44215

b-Nicotinamide adenine dinucleotide

BRN 3584133

UNII-0U46U6E8UK

diphosphopyridine nucleotide oxidized

NAD trihydrate

3-Carbamoyl-1-beta-D-ribofuranosylpyridinium hydroxide, 5-ester with adenosine 5-pyrophosphate, inner salt

NAD-oxidized

Nicotinamide adenine dinucleotide (NAD)

Nicotinamide-Adenine-Dinucleotide

NSC 20272

DPN-ox

Endopride

Adenosine 5-(trihydrogen diphosphate), P-5-ester with 3-(aminocarbonyl)-1-beta-D-ribofuranosylpyridinium hydroxide, inner salt

DPN+

Nadidum

Nadida

Adenosine 5-(trihydrogen diphosphate), P-5-ester with 3-(aminocarbonyl)-1-beta-D-ribofuranosylpyridinium, inner salt

NAD zwitterion

0U46U6E8UK

NAD Lithium salt

1-((2R,3R,4S,5R)-5-((((((((2R,3S,4R,5R)-5-(6-Amino-9H-purin-9-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methoxy)(hydroxy)phosphoryl)oxy)oxidophosphoryl)oxy)methyl)-3,4-dihydroxytetrahydrofuran-2-yl)-3-carbamoylpyridin-1-ium

Nadide USAN:INN:BAN:JAN

64417-72-7

Pyridinium, 3-carbamoyl-1-beta-D-ribofuranosyl-, hydroxide, 5-ester with adenosine 5-5-(trihydrogen pyrophosphate), inner salt

EINECS 200-184-4

beta-Nicotinamide adenine dinucleotide trihydrate

NSC20272

CAS-53-84-9

NCGC00016240-01

b-DPN

b-NAD

beta-Nicotinamide adenine dinucleotide hydrate

b-NAD, oxidised form

C-NAD

beta-NAD, oxidised form

adenylate-32-P-NAD

Carbonyl 14C NAD+

EC 200-184-4

NAD, Grade I, free acid

adenylate-32-P-NAD+

DSSTox_CID_25236

DSSTox_RID_80768

NAD, Grade II, free acid

DSSTox_GSID_45236

5-26-16-00399 (Beilstein Handbook Reference)

SCHEMBL131544

SPECTRUM1500419

Pyridine nucleotide diphosphate

GTPL2451

CHEMBL1234613

DTXSID2045236

HMS500J11

Nicotinamide Adinine Dinucleotide

14C NAD+

32P NAD+

BDBM213227

HMS2091H06

HMS2097E04

HMS3714E04

Pharmakon1600-01500419

EX-A3535

HY-B0445

Tox21_110321

6614AF

CCG-40114

NSC757121

s2518

AKOS015892319

beta-nicotinamide adenine din-ucleotide

CM11026

DB14128

NSC-757121

.beta.-Nicotinamide adenine dinucleotide

NCGC00178839-01

NCGC00178839-02

NCGC00178839-03

NCGC00178839-08

(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-ylmethoxy-hydroxyphosphoryl (2R,3S,4R,5R)-5-(3-carbamoylpyridin-1-ium-1-yl)-3,4-dihydroxyoxolan-2-ylmethyl phosphate

Adenosine 5-(trihydrogen diphosphate), 5-5-ester with 3-(aminocarbonyl)-1-beta-D-ribofuranosylpyridinium, hydroxide, inner salt

AS-14652

M041

SBI-0051451.P003

AB00513910

D0919

beta-Nicotinamide adenine dinucleotide, reduced

AB00052048_03

b-Nicotinamide adenine dinucleotide hydrate (NAD)

Nicotinamide adenine dinucleotideNAD+mono sodium salt

beta-Nicotinamide adenine dinucleotide hydrate, >=99%

Q12499775

F45C0D6C-DA87-47BE-9975-7A5DE9CCB985

beta-Nicotinamide adenine dinucleotide hydrate, >=95% (HPLC)

beta-Nicotinamide adenine dinucleotide, pkg of 10 mg (per vial)

beta-Nicotinamide adenine dinucleotide, pkg of 20 mg (per vial)

beta-Nicotinamide adenine dinucleotide, pkg of 50 mg (per vial)

beta-Nicotinamide adenine dinucleotide hydrate, >=98%, BioUltra, from yeast

beta-Nicotinamide adenine dinucleotide hydrate, Grade AA-1, >=95% (HPLC)

3-Carbamoyl-1-D-ribofuranosylpyridinium hydroxide 5-ester with adenosine 5-pyrophosphate

beta-Nicotinamide adenine dinucleotide hydrate, purified by column chromatography, >=99%

beta-Nicotinamide adenine dinucleotide hydrate, Vetec(TM) reagent grade, >=96.5%

(3S,2R,4R,5R)-5-(6-Aminopurin-9-yl)-3,4-dihydroxyoxolan-2-ylmethyl {(3S,2R,4R,5R)-5-(3-carbamoylpyridyl)-3,4-dihydroxyoxolan-2-ylmethoxy}(hydroxyphosphoryl) hydrogen phosphate

(3S,2R,4R,5R)-5-(6-Aminopurin-9-yl)-3,4-dihydroxyoxolan-2-ylmethyl {(3S,2R,4R,5R)-5-(3-carbamoylpyridyl)-3,4-dihydroxyoxolan-2-ylmethoxy}(hydroxyphosphoryl)hydrogen phosphate

(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxy-tetrahydrofuran-2-ylmethoxy-hydroxy-phosphoryl (2R,3S,4R,5R)-5-(3-carbamoylpyridin-1-ium-1-yl)-3,4-dihydroxy-tetrahydrofuran-2-ylmethyl hydrogen phosphate

3-Carbamoyl-1-beta-D-ribofuranosylpyridinium hydroxide 5-ester with adenosine 5-pyrophosphate inner salt"

3-Carbamoyl-1-beta-delta-ribofuranosylpyridinium hydroxide 5-ester with adenosine 5-pyrophosphate inner salt"

3-Carbamoyl-1-delta-ribofuranosylpyridinium hydroxide 5-ester with adenosine 5-pyrophosphate"

Adenosine 5-(trihydrogen diphosphate), P->5-ester with 3-(aminocarbonyl)-1-beta-D-ribofuranosylpyridinium, inner salt"

Adenosine 5-(trihydrogen diphosphate), P.fwdarw.5-ester with 3-(aminocarbonyl)-1-beta-D-ribofuranosylpyridinium, inner salt"

Adenosine 5-(trihydrogen diphosphate-P-32P), P>5-ester with 3-(aminocarbonyl)-1-beta-D-ribofuranosylpyridinium, inner salt (9CI)

beta-Nicotinamide adenine dinucleotide hydrate, >=96.5% (HPLC), >=96.5% (spectrophotometric assay), from yeast

beta-Nicotinamide adenine dinucleotide hydrate, cell culture tested, >=96.5% (HPLC), >=96.5% (spectrophotometric assay), from yeast

beta-Nicotinamide adenine dinucleotide hydrate, PharmaGrade, Manufactured under appropriate controls for use as a raw material in pharma or biopharmaceutical production.

beta-Nicotinamide adenine dinucleotide hydrate, Suitable for manufacturing of diagnostic kits and reagents

Pyridinium, 3-carbamoyl-1-b-D-ribofuranosyl-, hydroxide, 5-5-ester with adenosine 5-(trihydrogen pyrophosphate), inner salt (8CI)"
  Experimental Data
 nadide

Species Dose Unit Control(Avg days) Treatment(Avg days) Avg/Med Lifespan Change(%) Control(Max days) Treatment(Max days) Max Lifespan Change(%) Significant Strain Gender PubMed Avg/Med Lifespan Change tab
Caenorhabditis elegans 100.000000000000000 umol/L 15.000000000000000 S N2 19370397 Active
  Experimental Data Visualization
 nadide

  Statistics Data
 nadide

Species Avg/Med Lifespan Change(%) Max Lifespan Change(%) Count Reference Count Data point
Caenorhabditis elegans 15.000000000000000 1 1
  Statistics Data Visualization
 nadide

Home | Browse | Search | Predict | Data | Contact | Help

Copyright © KUST | 滇ICP备16009434号-1 | Dai SX Lab